UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Knowing when to choose investment over savings is crucial for financial growth. Timing your decisions can significantly impact your financial future.
25,463 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
HYPE breaks above $57 as a short squeeze pushes the token within 2% of its all-time high, with negative funding and s...
Lionsgate delivered stronger-than-expected results, and its stock jumped. This article breaks down the key factors be...
A narrow, theme-driven ETF focused on generative AI shows mixed results as broader AI funds rally. The concentrated a...
Experts say a $2 million portfolio can support retirement if you follow a disciplined, flexible withdrawal rule rathe...
SoFi posted stronger Q1 2026 results, but the stock remains depressed as investors weigh the path to sustained profit...
Uber is dialing back its push on wide AI bets, choosing measured investments aimed at ROI and platform reliability. T...
Nebius stock has drawn attention for rapid AI cloud growth, but two core risks could derail momentum. This guide give...
A growing debate questions whether pure dividend stocks replace a $110,000 annual household income. This report break...
The latest payroll data show a strong labor market, boosting yields and challenging expectations for quick Fed rate c...
Analysts are weighing a path for synopsys stock $600 march targets as AI-driven chip design demand grows, even as deb...
Senate Democrats on June 4 unveiled legislation to lock in funding for the CFPB, aiming to prevent political interfer...